• رئيس جامعة دمنهور يفتتح دورات التنمية البشرية في كلية الصيدلة
  • رمضان كريم
 
 
 

اخر الأخبار
خبر هاااام للطلاب........الطلاب الذين لم يحضروا السته جند سيتم حرمانهم من دخول الأمتحانعلى الطلاب الذين لم يسددوا مصروفات برنامج الصيدلة الأكلينيكية بقسم شوؤن الطلاب سيتم حرمانهم من دخول امتحان منتصف الترمبكل الحب واعزاز وتقدير احتفل اليوم قسم الكيمياء الصيدلية _ بكلية الصيدلة _ جامعة دمنهور بعودة الأستاذة الدكتورة / هدى دعبيس للعمل بالقسم كأستاذ كيمياء صيدلية0أحتفالية كلية الصيدلة – جامعة دمنهور بمؤسس كلية الصيدلة الاستاذة الدكتورة / هدى دعبيس عميد كلية الصيدلة ونائب رئيس الجامعة للدراسات العليا والبحوث الأسبق متمنين لسيادتها مزيد من العطاء والنجاح وأن يمتعها بدوام الصحة والعافية .

 

 

إعداد/ وحده IT كليه الصيدله جامعه دمنهور

 

(الأدويه والسموم) أبحاث القسم

 

1- Randomized placebo-controlled study of baclofen in the treatment of muscle cramps in patients with liver cirrhosisAsem A. Elferta, Lobna Abo Alia, Samah Solimana, Sherin Zakariab, Ibrahim Shehab El-Dina, Walaa Elkhalawanya and Sherief Abd-Elsalama, Click Here

2- Novel moleculartriggers underlie valproate-induced liver injuryanditsalleviation by theomega-3fattyacid DHA: roleofinflammation and apoptosis

Abdalla M.El-Mowafy a,b,*, MohamedM.Katary c,d, ChelseyPye c, Ahmed S.Ibrahim a,c, AhmedA.Elmarakby c,*

3- Meloxicam fails to augment the reno-protective effects of solubleepoxide hydrolase inhibition in streptozotocin-induced diabetic ratsvia increased 20-HETE levels

Mohamed M. Katarya,b, Chelsey Pyea, Ahmed A. Elmarakby (Ph.D., FAHA) (R.Ph.)a,∗

4- N- acetyl cysteine Possible Protector Against Experimentally Indomethacin Induced Peptic Ulcer: Cross talks between Antioxidant, Anti-inflammatory and Anti-apoptotic Mechanisms

Nema Ali Soliman1*, Doaa Hussein Zineldeen1, Mohamed Alaa Katary2, Darin Abd El Aziz Ali3

5- Transforming Growth Factor-β1/ Smad3 Signaling and Redox Status in Experimentally Induced Nephrotoxicity: Impact of Carnosine

Walaa Arafa Keshk & Mohamed Alaa Katary

6- Gastroprotective Effect of Vanillin on Indomethacin-Induced Gastric Ulcer in Rats: Protective Pathways and Anti-Secretory Mechanism Katary MA1 and Salahuddin A2*

7- Fingerprint profile and efficacy-associated markers of Nigella sativa oil for geographical origin determination using targeted and untargeted HPTLC-multivariate analysis EmanShawkyaNihal M.El NewehybAmira M.BeltagybMohammad M.Abd-AlhaseebdGamal A.OmrancFathallah M.Harraz  ClickHere

8- Design, Optimization and Characterization of a Transfersomal Gel Using Miconazole Nitrate for the Treatment of Candida Skin Infections ,

9- Hesperidin, piperine and bee venom synergistically potentiate the anticancer effect of tamoxifen against breast cancer cells Abeer A.A.Khamis, Ehab M.M.Ali, Mohamed A. AbdEl-Moneim, Mohammad M.Abd-Alhaseeb, Mohammed AbuEl-Magd,
Elsayed I.Salim Click Here

10- Novel Proniosomes as Drug Delivery System for Transdermal Application of Itraconazole: Development, Characterization, Clinical and Bioavailability Study  A. Egunyomi || O.O. Oyesiku || A.O. Bolaji

11- Helmy M.W., Sharabi F.M., Rizk R.E., and Ismail S.S. (2005): Comparative effects of tamoxifen versus anastrozole in an experimental mammary carcinogenesis model. JMRI., 26: 1-6.

12- Ahmed O. Elzoghby, Maged W. Helmy, Wael M. Samy, Nazik A. Elgindy. Novel ionically crosslinked casein nanoparticles for flutamide delivery: formulation, characterization, and in vivo pharmacokinetics. International Journal of Nanomedicine. 2013:8 1721–1732

13- Ahmed O. Elzoghby , Maged W. Helmy, Wael M. Samy, Nazik A. Elgindy. Spray-dried casein-based micelles as a vehicle for solubilization and controlled delivery of flutamide: Formulation, characterization, and in vivo pharmacokineticsEur. J. Pharm. Biopharm. 2013 Aug;84(3):487-96

14-  Ahmed O. Elzoghby, Maged W. Helmy, Wael M. Samy, Nazik A. Elgindy. Micellar delivery of flutamide via milk protein nanovehicles enhances its anti-tumor efficacy in androgen-dependent prostate cancer rat model.Pharm. Res.  2013 Oct;30(10):2654-63

15- Ahmed O. Elzoghby, Noha I. Saad, Maged W. Helmy, Wael M. Samy, Nazik A. Elgindy.  Ionically-crosslinked milk protein nanoparticles as flutamide carriers for effective anticancer activity in prostate cancer-bearing rats. Eur J Pharm Biopharm.2013 Aug;85(3):444-51

16- Hanan M. El-Gowelli, Maged W. Helmy, Rabab M. Ali, Mahmoud M. El-Mas. Celecoxib offsets the negative renal influences of cyclosporine via modulation of the TGF-β1/IL-2/COX-2/endothelin ETB receptor cascade. Toxicology and Applied Pharmacology. 2014.  Toxicology and Applied Pharmacology 275 (2014) 88–95

17- Mai M. Helmy, Maged W. Helmy, Dina M. Abd Allah , Ahmad M. Abo Zaid, Mahmoud M. Mohy El-Din Mohy El-Din.Selective ETA receptor blockade protects against cisplatin-induced acute renal failure in male rats. European Journal of Pharmacology 730 (2014) 133–139

18- Maged W. Helmy, Mai M. Helmy, Dina M. Abd Allah, Ahmad M. Abo Zaid, Mahmoud M. Mohy El-Din Mohy El-Din.Role of nitrergic and endothelin pathways modulations in cisplatin-induced nephrotoxicity in male rats.  JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY 2014, 65, 3, 393-399

19- Mahmoud M El-Mas,Maged W Helmy,, Rabab M Abdel-Halim, and Hanan M El-Gowelli. Celecoxib, but not indomethacin, ameliorates the hypertensive and perivascular fibrotic actions of cyclosporine in rats: Role of endothelin signaling. Toxicology and Applied Pharmacology 284 (2015) 1–7.

20- Maged W. Helmy, Hanan M. El-Gowelli, Rabab M. Ali, Mahmoud M. El-Mas.Endothelin ETA receptor/lipid peroxides/COX-2/TGF-β1 signaling underlies aggravated nephrotoxicity caused by cyclosporine plus indomethacin in rats. British Journal Of Pharmacology 05/2015; DOI: 10.1111/bph.13199

21- MM Helmy,MW Helmy, MM El-Mas. Additive Renoprotection by Pioglitazone and Fenofibrate against Inflammatory, Oxidative and Apoptotic Manifestations of Cisplatin Nephrotoxicity: Modulation by PPARs. PloS one, 2015; 10 (11),  e014230.

22- AS Hanafy, RM Farid,MW Helmy, SS ElGamal. Pharmacological, toxicological and neuronal localization assessment of galantamine/chitosan complex nanoparticles in rats: future potential contribution in Alzheimer’s disease management. Drug delivery, 20167

23- Elzoghby AO, Mostafa SK, Helmy MW, El-Demellawy M, Shewita S, Superiority of aromatase inhibitor and cyclooxygenase-2 inhibitor combined delivery: Hyaluronate-targeted versus PEGylated protamine nanocapsulesfor breast cancer therapy, Int J Pharm 529 (2017) 178-192.

24- Elzoghby AO, Mostafa SK, Helmy MW, El-Demellawy M, Shewita S.Multi-Reservoir Phospholipid Shell Encapsulating Protamine Nanocapsules for Co-Delivery of Letrozole and Celecoxib In Breast Cancer Therapy. Pharm Res 34 (2017) 1956–1969.

25- Ahmed O Elzoghby, Sarah A El-Lakany, Maged W Helmy, Marwa M Abu-Serie, Nazik A Elgindy. Shell-crosslinked zein nanocapsules for oral codelivery of exemestane and resveratrol in breast cancer therapy. Nanomedicine 12 (24) (2017), 2785-2805

26- Shaymaa W El-Far, Maged W Helmy, Sherine N Khattab, Adnan A Bekhit, Ahmed A Hussein, Ahmed O Elzoghby. Phytosomal bilayer-enveloped casein micelles for codelivery of monascus yellow pigments and resveratrol to breast cancer. Nanomedicine 13 (5) (2018), 481-499

27- Maged W Helmy, Mai M Helmy, Mahmoud M El-Mas.Enhanced lipoxygenase/LTD4 activity accounts for the exaggerated hypertensive and nephrotoxic effects of cyclosporine plus indomethacin in rats. Biomedicine & Pharmacotherapy (2018) 102, 309-316

28 -Dalia M Kabary, Maged W Helmy, Kadria A Elkhodairy, Jia-You Fang, Ahmed O Elzoghby. Hyaluronate/lactoferrin layer-by-layer-coated lipid nanocarriers for targeted co-delivery of rapamycin and berberine to lung carcinoma. Colloids and Surfaces B: Biointerfaces (2018) 169, 183-194

29- Sally A Sabra, Ahmed O Elzoghby, Salah A Sheweita, Medhat Haroun, Maged W Helmy, Maha A Eldemellawy, Ying Xia, David Goodale, Alison L Allan, Sohrab Rohani. Self-assembled amphiphilic zein-lactoferrin micelles for tumor targeted co-delivery of rapamycin and wogonin to breast cancer. European Journal of Pharmaceutics and Biopharmaceutics (2018)128, 156-169

30- Mayada M Elgohary, Maged W Helmy, Elsayeda-Zeinab A Abdelfattah, Doaa M Ragab, Sana M Mortada, Jia-You Fang, Ahmed O Elzoghby. Targeting sialic acid residues on lung cancer cells by inhalable boronic acid-decorated albumin nanocomposites for combined chemo/herbal therapy.Journal of Controlled Release (2018)285, 230-243

31- Rabab M Ali, Muhammad Y Al-Shorbagy, Maged W Helmy, Hanan S El-Abhar. Role of Wnt4/β-catenin, Ang Ii/tgfβ, Ace2, Nf-κb, and Il-18 in attenuating renal ischemia/reperfusion-induced injury in rats treated with Vit D and pioglitazone. European journal of pharmacology (2018) 831, 68-76

32- Tarek K Motawi, Hebatallah A Darwish, Iman Diab, Maged W Helmy, Mohamed H Noureldin. Combinatorial strategy of epigenetic and hormonal therapies: A novel promising approach for treating advanced prostate cancer. Life sciences (2018) 198, 71-78

33- Maged W. Helmy, Mai M. Helmy, Mahmoud M. El-Mas.Enhanced lipoxygenase/LTD4 signaling accounts for the exaggerated hypertensive and nephrotoxic eects of cyclosporine plus indomethacin in rats.Biomedicine & Pharmacotherapy 102 (2018) 309–316.

34- Shaymaa W El-Far, Maged W Helmy, Sherine N Khattab, Adnan A Bekhit1, Ahmed A Hussein & Ahmed O Elzoghby. Folate conjugated vs PEGylated phytosomal casein nanocarriers for codelivery of fungaland herbal-derived anticancer drugs. Nanomedicine (Lond.)(2018)13(12), 1463–1480

35- Rabab M. Alia, Muhammad Y. Al-Shorbagy, Maged W. Helmy, Hanan S. El-Abhar.Role of Wnt4/β-catenin, Ang II/TGFβ, ACE2, NF-κB, and IL-18 in attenuating renal ischemia/reperfusion-induced injury in rats treated with Vit D and pioglitazone. European Journal of Pharmacology 831 (2018) 68–76

36- Sally A. Sabraa, Ahmed O. Elzoghby, Salah A. Sheweita, Medhat Haroun, Maged W. Helmy, Maha A. Eldemellawy, Ying Xiag, David Goodale, Alison L. Allang, Sohrab Rohani.Self-assembled amphiphilic zein-lactoferrin micelles for tumor targeted codelivery of rapamycin and wogonin to breast cancer. European Journal of Pharmaceutics and Biopharmaceutics 128 (2018) 156–169

37- Ahmed S AbdElhamid, Maged W Helmy, Shaker M Ebrahim, Mohammed Bahey-El-Din, Dina G Zayed, Esmat A Zein El Dein, Sanaa A El-Gizawy & Ahmed O Elzoghby.Layer-by-layer gelatin/chondroitin quantum dots-based nanotheranostics: combined rapamycin/celecoxib delivery and cancer imaging. Nanomedicine (Lond). 2018 Aug 3. doi: 10.2217/nnm-2018-0028.

38- Dalia M. Kabary, Maged W. Helmy, Kadria A. Elkhodairy, Jia-You Fange, Ahmed O. Elzoghby.Hyaluronate/lactoferrin layer-by-layer-coated lipid nanocarriers fortargeted co-delivery of rapamycin and berberine to lung carcinoma. Colloids and Surfaces B: Biointerfaces 169 (2018) 183–194

39- Mahmoud M Abd Elwakil, Moustafa T Mabrouk, Maged W Helmy, Elsayeda-Zeinab A Abdelfattah, Sachin K Khiste, Kadria A Elkhodairy & Ahmed O Elzoghby. Inhalable lactoferrin–chondroitin nanocomposites for combined delivery of doxorubicin and ellagic acid to lung carcinoma. Nanomedicine (Lond). 2018 Aug; 13(16):2015-2035.

40- Dalia M. Kabary, Maged W. Helmy, Elsayeda-Zeinab A. Abdelfattahe, Jia-You Fang, Kadria A. Elkhodairy, Ahmed O. Elzoghby,Inhalable multi-compartmental phospholipid enveloped lipid core nanocomposites for localized mTOR inhibitor/herbal combined therapy of lung carcinoma. European Journal of Pharmaceutics and Biopharmaceutics 130 (2018) 152–164

41- Mayada M. Elgohary, Maged W. Helmy, Elsayeda-Zeinab A. Abdelfattahd, Doaa M. Ragabb, Sana M. Mortada, Jia-You Fange, Ahmed O. Elzoghby.Targeting sialic acid residues on lung cancer cells by inhalable boronic acid decorated albumin nanocomposites for combined chemo/herbal therapy. Journal of Controlled Release 285 (2018) 230–243

42- Mayada M Elgohary, Maged W Helmy, Sana M Mortada & Ahmed O Elzoghby.Dual-Targeted Nano-in-Nano Albumin Carriers Enhance The Efficacy of Combined Chemo/Herbal Therapy of Lung Cancer. Nanomedicine (Lond). 2018 Sep; 13(17):2221-2224. doi: 10.2217/nnm-2018-0097.

43- Ahmed S AbdElhamid, Dina G Zayed, Maged W Helmy, Shaker M Ebrahim, Mohammed Bahey-El-Din, Esmat A Zein-El-Dein, Sanaa A El-Gizawy & Ahmed O Elzoghby. Lactoferrin-tagged quantum dots-based theranostic nanocapsules for combined COX-2 inhibitor/herbal therapy of breast Cancer. Nanomedicine (Lond). 2018 Oct 19. doi: 10.2217/nnm-2018-0196

44- Anwar DMKhattab SNHelmy MW, Kamal MKBekhit AAElkhodairy KAElzoghby AO.Lactobionic/Folate Dual-Targeted Amphiphilic Maltodextrin-Based Micelles for Targeted Codelivery of Sulfasalazine and Resveratrol to Hepatocellular Carcinoma. Bioconjug Chem. 2018 Sep 19;29(9):3026-3041.

45- Sarah A. El-Lakany, Nazik A. Elgindy, Maged W. Helmy, Marwa M Abu-Serie & Ahmed O. Elzoghby.Lactoferrin-decorated vs. PEGylated zein nanospheres for combined aromatase inhibitor and herbal therapy of breast cancer. Expert Opin Drug Deliv. 2018 Sep; 15(9):835-850.

46- Mona A. Abdelmoneem, Mazen Mahmoud, Amira Zaky, Maged W. Helmy, Marwa Sallam, Jia-You Fange, Kadria A. Elkhodairy, Ahmed O. ElzoghbyDual-targeted casein micelles as green nanomedicine for synergistic phytotherapy of hepatocellular carcinoma. Journal of Controlled Release 287 (2018) 78–93

47- Fatma M. Abdallah, Maged W. Helmy, Mohamed A. Katary, Asser I. Ghoneim. Synergistic antiproliferative effects of curcumin and celecoxib in hepatocellular carcinoma HepG2 cells. Naunyn Schmiedebergs Arch Pharmacol. 2018 Dec; 391(12):1399-1410. 

48- Sherin Zakariaa, Maged Wasfy Helmy, Ahmed Salahuddic, Gamal Omran.Chemopreventive and antitumor effects of benzyl isothiocynate on HCC models: A possible role of HGF /pAkt/ STAT3 axis and VEGF. Biomedicine & Pharmacotherapy 108 (2018) 65–75

49- Ibrahim El Sayed, Maged W. Helmy,Hanan S. El-Abhar.Inhibition of SRC/FAK cue: A novel pathway for the synergistic effect of rosuvastatin on the anti-cancer effect of dasatinib in hepatocellular carcinoma.Life Sciences 213 (2018) 248–257

50- Helmy M.W., Sharabi F.M., Rizk R.E., and Ismail S.S. (2005): Comparative effects of tamoxifen versus anastrozole in an experimental mammary carcinogenesis model. JMRI., 26: 1-6.

51- Ahmed O. Elzoghby, Maged W. Helmy, Wael M. Samy, Nazik A. Elgindy. Novel ionically crosslinked casein nanoparticles for flutamide delivery: formulation, characterization, and in vivo pharmacokinetics. International Journal of Nanomedicine. 2013:8 1721–1732

52- Ahmed O. Elzoghby , Maged W. Helmy, Wael M. Samy, Nazik A. Elgindy. Spray-dried casein-based micelles as a vehicle for solubilization and controlled delivery of flutamide: Formulation, characterization, and in vivo pharmacokineticsEur. J. Pharm. Biopharm. 2013 Aug;84(3):487-96

53- Ahmed O. Elzoghby, Maged W. Helmy, Wael M. Samy, Nazik A. Elgindy. Micellar delivery of flutamide via milk protein nanovehicles enhances its anti-tumor efficacy in androgen-dependent prostate cancer rat model.Pharm. Res.  2013 Oct;30(10):2654-63

54- Ahmed O. Elzoghby, Noha I. Saad, Maged W. Helmy, Wael M. Samy, Nazik A. Elgindy.  Ionically-crosslinked milk protein nanoparticles as flutamide carriers for effective anticancer activity in prostate cancer-bearing rats. Eur J Pharm Biopharm.2013 Aug;85(3):444-51

55- Hanan M. El-Gowelli, Maged W. Helmy, Rabab M. Ali, Mahmoud M. El-Mas. Celecoxib offsets the negative renal influences of cyclosporine via modulation of the TGF-β1/IL-2/COX-2/endothelin ETB receptor cascade. Toxicology and Applied Pharmacology. 2014.  Toxicology and Applied Pharmacology 275 (2014) 88–95

56- Mai M. Helmy, Maged W. Helmy, Dina M. Abd Allah , Ahmad M. Abo Zaid, Mahmoud M. Mohy El-Din Mohy El-Din.Selective ETA receptor blockade protects against cisplatin-induced acute renal failure in male rats. European Journal of Pharmacology 730 (2014) 133–139

57- Maged W. Helmy, Mai M. Helmy, Dina M. Abd Allah, Ahmad M. Abo Zaid, Mahmoud M. Mohy El-Din Mohy El-Din.Role of nitrergic and endothelin pathways modulations in cisplatin-induced nephrotoxicity in male rats.  JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY 2014, 65, 3, 393-399

58- Mahmoud M El-Mas,Maged W Helmy,, Rabab M Abdel-Halim, and Hanan M El-Gowelli. Celecoxib, but not indomethacin, ameliorates the hypertensive and perivascular fibrotic actions of cyclosporine in rats: Role of endothelin signaling. Toxicology and Applied Pharmacology 284 (2015) 1–7.

59- Maged W. Helmy, Hanan M. El-Gowelli, Rabab M. Ali, Mahmoud M. El-Mas.Endothelin ETA receptor/lipid peroxides/COX-2/TGF-β1 signaling underlies aggravated nephrotoxicity caused by cyclosporine plus indomethacin in rats. British Journal Of Pharmacology 05/2015; DOI: 10.1111/bph.13199

60- MM Helmy,MW Helmy, MM El-Mas. Additive Renoprotection by Pioglitazone and Fenofibrate against Inflammatory, Oxidative and Apoptotic Manifestations of Cisplatin Nephrotoxicity: Modulation by PPARs. PloS one, 2015; 10 (11),  e014230.

61- AS Hanafy, RM Farid,MW Helmy, SS ElGamal. Pharmacological, toxicological and neuronal localization assessment of galantamine/chitosan complex nanoparticles in rats: future potential contribution in Alzheimer’s disease management. Drug delivery, 2016

62- Elzoghby AO, Mostafa SK, Helmy MW, El-Demellawy M, Shewita S, Superiority of aromatase inhibitor and cyclooxygenase-2 inhibitor combined delivery: Hyaluronate-targeted versus PEGylated protamine nanocapsulesfor breast cancer therapy, Int J Pharm 529 (2017) 178-192.

63- Elzoghby AO, Mostafa SK, Helmy MW, El-Demellawy M, Shewita S.Multi-Reservoir Phospholipid Shell Encapsulating Protamine Nanocapsules for Co-Delivery of Letrozole and Celecoxib In Breast Cancer Therapy. Pharm Res 34 (2017) 1956–1969.

64- Ahmed O Elzoghby, Sarah A El-Lakany, Maged W Helmy, Marwa M Abu-Serie, Nazik A Elgindy. Shell-crosslinked zein nanocapsules for oral codelivery of exemestane and resveratrol in breast cancer therapy. Nanomedicine 12 (24) (2017), 2785-2805

65- Shaymaa W El-Far, Maged W Helmy, Sherine N Khattab, Adnan A Bekhit, Ahmed A Hussein, Ahmed O Elzoghby. Phytosomal bilayer-enveloped casein micelles for codelivery of monascus yellow pigments and resveratrol to breast cancer. Nanomedicine 13 (5) (2018), 481-499

666- Maged W Helmy, Mai M Helmy, Mahmoud M El-Mas.Enhanced lipoxygenase/LTD4 activity accounts for the exaggerated hypertensive and nephrotoxic effects of cyclosporine plus indomethacin in rats. Biomedicine & Pharmacotherapy (2018) 102, 309-316

67- Dalia M Kabary, Maged W Helmy, Kadria A Elkhodairy, Jia-You Fang, Ahmed O Elzoghby. Hyaluronate/lactoferrin layer-by-layer-coated lipid nanocarriers for targeted co-delivery of rapamycin and berberine to lung carcinoma. Colloids and Surfaces B: Biointerfaces (2018) 169, 183-194

68- Sally A Sabra, Ahmed O Elzoghby, Salah A Sheweita, Medhat Haroun, Maged W Helmy, Maha A Eldemellawy, Ying Xia, David Goodale, Alison L Allan, Sohrab Rohani. Self-assembled amphiphilic zein-lactoferrin micelles for tumor targeted co-delivery of rapamycin and wogonin to breast cancer. European Journal of Pharmaceutics and Biopharmaceutics (2018)128, 156-169

69- Mayada M Elgohary, Maged W Helmy, Elsayeda-Zeinab A Abdelfattah, Doaa M Ragab, Sana M Mortada, Jia-You Fang, Ahmed O Elzoghby. Targeting sialic acid residues on lung cancer cells by inhalable boronic acid-decorated albumin nanocomposites for combined chemo/herbal therapy.Journal of Controlled Release (2018)285, 230-243

70- Rabab M Ali, Muhammad Y Al-Shorbagy, Maged W Helmy, Hanan S El-Abhar. Role of Wnt4/β-catenin, Ang Ii/tgfβ, Ace2, Nf-κb, and Il-18 in attenuating renal ischemia/reperfusion-induced injury in rats treated with Vit D and pioglitazone. European journal of pharmacology (2018) 831, 68-76

71- Tarek K Motawi, Hebatallah A Darwish, Iman Diab, Maged W Helmy, Mohamed H Noureldin. Combinatorial strategy of epigenetic and hormonal therapies: A novel promising approach for treating advanced prostate cancer. Life sciences (2018) 198, 71-78

72- Maged W. Helmy, Mai M. Helmy, Mahmoud M. El-Mas.Enhanced lipoxygenase/LTD4 signaling accounts for the exaggerated hypertensive and nephrotoxic eects of cyclosporine plus indomethacin in rats.Biomedicine & Pharmacotherapy 102 (2018) 309–316.

73- Shaymaa W El-Far, Maged W Helmy, Sherine N Khattab, Adnan A Bekhit1, Ahmed A Hussein & Ahmed O Elzoghby. Folate conjugated vs PEGylated phytosomal casein nanocarriers for codelivery of fungaland herbal-derived anticancer drugs. Nanomedicine (Lond.)(2018)13(12), 1463–1480

74- Rabab M. Alia, Muhammad Y. Al-Shorbagy, Maged W. Helmy, Hanan S. El-Abhar.Role of Wnt4/β-catenin, Ang II/TGFβ, ACE2, NF-κB, and IL-18 in attenuating renal ischemia/reperfusion-induced injury in rats treated with Vit D and pioglitazone. European Journal of Pharmacology 831 (2018) 68–76

75- Sally A. Sabraa, Ahmed O. Elzoghby, Salah A. Sheweita, Medhat Haroun, Maged W. Helmy, Maha A. Eldemellawy, Ying Xiag, David Goodale, Alison L. Allang, Sohrab Rohani.Self-assembled amphiphilic zein-lactoferrin micelles for tumor targeted codelivery of rapamycin and wogonin to breast cancer. European Journal of Pharmaceutics and Biopharmaceutics 128 (2018) 156–169

76- Ahmed S AbdElhamid, Maged W Helmy, Shaker M Ebrahim, Mohammed Bahey-El-Din, Dina G Zayed, Esmat A Zein El Dein, Sanaa A El-Gizawy & Ahmed O Elzoghby.Layer-by-layer gelatin/chondroitin quantum dots-based nanotheranostics: combined rapamycin/celecoxib delivery and cancer imaging. Nanomedicine (Lond). 2018 Aug 3. doi: 10.2217/nnm-2018-0028.

77- Dalia M. Kabary, Maged W. Helmy, Kadria A. Elkhodairy, Jia-You Fange, Ahmed O. Elzoghby.Hyaluronate/lactoferrin layer-by-layer-coated lipid nanocarriers fortargeted co-delivery of rapamycin and berberine to lung carcinoma. Colloids and Surfaces B: Biointerfaces 169 (2018) 183–194

78- Mahmoud M Abd Elwakil, Moustafa T Mabrouk, Maged W Helmy, Elsayeda-Zeinab A Abdelfattah, Sachin K Khiste, Kadria A Elkhodairy & Ahmed O Elzoghby. Inhalable lactoferrin–chondroitin nanocomposites for combined delivery of doxorubicin and ellagic acid to lung carcinoma. Nanomedicine (Lond). 2018 Aug; 13(16):2015-2035.

79- Dalia M. Kabary, Maged W. Helmy, Elsayeda-Zeinab A. Abdelfattahe, Jia-You Fang, Kadria A. Elkhodairy, Ahmed O. Elzoghby,Inhalable multi-compartmental phospholipid enveloped lipid core nanocomposites for localized mTOR inhibitor/herbal combined therapy of lung carcinoma. European Journal of Pharmaceutics and Biopharmaceutics 130 (2018) 152–164

80- Mayada M. Elgohary, Maged W. Helmy, Elsayeda-Zeinab A. Abdelfattahd, Doaa M. Ragabb, Sana M. Mortada, Jia-You Fange, Ahmed O. Elzoghby.Targeting sialic acid residues on lung cancer cells by inhalable boronic acid decorated albumin nanocomposites for combined chemo/herbal therapy. Journal of Controlled Release 285 (2018) 230–243

81- Mayada M Elgohary, Maged W Helmy, Sana M Mortada & Ahmed O Elzoghby.Dual-Targeted Nano-in-Nano Albumin Carriers Enhance The Efficacy of Combined Chemo/Herbal Therapy of Lung Cancer. Nanomedicine (Lond). 2018 Sep; 13(17):2221-2224. doi: 10.2217/nnm-2018-0097.

82- Ahmed S AbdElhamid, Dina G Zayed, Maged W Helmy, Shaker M Ebrahim, Mohammed Bahey-El-Din, Esmat A Zein-El-Dein, Sanaa A El-Gizawy & Ahmed O Elzoghby. Lactoferrin-tagged quantum dots-based theranostic nanocapsules for combined COX-2 inhibitor/herbal therapy of breast Cancer. Nanomedicine (Lond). 2018 Oct 19. doi: 10.2217/nnm-2018-0196

83- Anwar DMKhattab SNHelmy MW, Kamal MKBekhit AAElkhodairy KAElzoghby AO.Lactobionic/Folate Dual-Targeted Amphiphilic Maltodextrin-Based Micelles for Targeted Codelivery of Sulfasalazine and Resveratrol to Hepatocellular Carcinoma. Bioconjug Chem. 2018 Sep 19;29(9):3026-3041.

84- Sarah A. El-Lakany, Nazik A. Elgindy, Maged W. Helmy, Marwa M Abu-Serie & Ahmed O. Elzoghby.Lactoferrin-decorated vs. PEGylated zein nanospheres for combined aromatase inhibitor and herbal therapy of breast cancer. Expert Opin Drug Deliv. 2018 Sep; 15(9):835-850.

85- Mona A. Abdelmoneem, Mazen Mahmoud, Amira Zaky, Maged W. Helmy, Marwa Sallam, Jia-You Fange, Kadria A. Elkhodairy, Ahmed O. ElzoghbyDual-targeted casein micelles as green nanomedicine for synergistic phytotherapy of hepatocellular carcinoma. Journal of Controlled Release 287 (2018) 78–93

86- Fatma M. Abdallah, Maged W. Helmy, Mohamed A. Katary, Asser I. Ghoneim. Synergistic antiproliferative effects of curcumin and celecoxib in hepatocellular carcinoma HepG2 cells. Naunyn Schmiedebergs Arch Pharmacol. 2018 Dec; 391(12):1399-1410. 

87- Sherin Zakariaa, Maged Wasfy Helmy, Ahmed Salahuddic, Gamal Omran.Chemopreventive and antitumor effects of benzyl isothiocynate on HCC models: A possible role of HGF /pAkt/ STAT3 axis and VEGF. Biomedicine & Pharmacotherapy 108 (2018) 65–75

88- Ibrahim El Sayed, Maged W. Helmy,Hanan S. El-Abhar.Inhibition of SRC/FAK cue: A novel pathway for the synergistic effect of rosuvastatin on the anti-cancer effect of dasatinib in hepatocellular carcinoma.Life Sciences 213 (2018) 248–257

 

 

 

 

أخر تحديث للصفحة : 11/3/2018 10:48:31 PM
عدد القراءات : 917


جميع الحقوق محفوظة لجامعة دمنهور © 2016
تصميم وتنفيذ مشروع البوابة الإلكترونية 
انت الزائر رقم
251703